# Pletaal SR Post Marketing Observational Study

> **NCT01782833** · — · COMPLETED · sponsor: **Korea Otsuka Pharmaceutical Co., Ltd.** · enrollment: 3635 (actual)

## Conditions studied

- Ischemic Symptoms
- Cerebral Infarction

## Interventions

- **OTHER:** This is Non-interventional study

## Key facts

- **NCT ID:** NCT01782833
- **Lead sponsor:** Korea Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-12-31
- **Final completion:** 2014-12-31
- **Target enrollment:** 3635 (ACTUAL)
- **Last updated:** 2019-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01782833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01782833, "Pletaal SR Post Marketing Observational Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01782833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*